Patents by Inventor Nicholas B. Lydon

Nicholas B. Lydon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMMUNOGLOBULINS AND VARIANTS DIRECTED AGAINST PATHOGENIC MICROBES
    Publication number: 20220002392
    Abstract: Anti-SpA murine, chimeric and humanized monoclonal antibodies, and variant antibodies having a heavy chain with at least one amino acid substitution are provided. Such antibodies may be used to prevent or treat microbial infections.
    Type: Application
    Filed: February 8, 2021
    Publication date: January 6, 2022
    Inventor: Nicholas B. Lydon
  • Immunoglobulins and variants directed against pathogenic microbes
    Patent number: 10941193
    Abstract: Anti-microbial monoclonal antibodies and variant antibodies having a heavy chain constant regions with at least one amino acid substitution are provided. Such antibodies may be used to prevent or treat microbial infections.
    Type: Grant
    Filed: August 15, 2016
    Date of Patent: March 9, 2021
    Inventor: Nicholas B. Lydon
  • Immunoglobulins and variants directed against pathogenic microbes
    Patent number: 10913791
    Abstract: Anti-SpA murine, chimeric and humanized monoclonal antibodies, and variant antibodies having a heavy chain with at least one amino acid substitution are provided. Such antibodies may be used to prevent or treat microbial infections.
    Type: Grant
    Filed: October 28, 2019
    Date of Patent: February 9, 2021
    Inventor: Nicholas B. Lydon
  • IMMUNOGLOBULINS AND VARIANTS DIRECTED AGAINST PATHOGENIC MICROBES
    Publication number: 20200291099
    Abstract: Anti-SpA murine, chimeric and humanized monoclonal antibodies, and variant antibodies having a heavy chain with at least one amino acid substitution are provided. Such antibodies may be used to prevent or treat microbial infections.
    Type: Application
    Filed: October 28, 2019
    Publication date: September 17, 2020
    Inventor: Nicholas B. Lydon
  • Immunoglobulins and variants directed against pathogenic microbes
    Patent number: 10457723
    Abstract: Anti-SpA murine, chimeric and humanized monoclonal antibodies, and variant antibodies having a heavy chain with at least one amino acid substitution are provided. Such antibodies may be used to prevent or treat microbial infections.
    Type: Grant
    Filed: February 15, 2017
    Date of Patent: October 29, 2019
    Inventor: Nicholas B. Lydon
  • Immunoglobulins and variants directed against pathogenic microbes
    Patent number: 9988439
    Abstract: Anti-SpA murine, chimeric and humanized monoclonal antibodies, and variant antibodies having a heavy chain with at least one amino acid substitution are provided. Such antibodies may be used to prevent or treat microbial infections.
    Type: Grant
    Filed: June 27, 2014
    Date of Patent: June 5, 2018
    Inventor: Nicholas B. Lydon
  • IMMUNOGLOBULINS AND VARIANTS DIRECTED AGAINST PATHOGENIC MICROBES
    Publication number: 20170226195
    Abstract: Anti-SpA murine, chimeric and humanized monoclonal antibodies, and variant antibodies having a heavy chain with at least one amino acid substitution are provided. Such antibodies may be used to prevent or treat microbial infections.
    Type: Application
    Filed: February 15, 2017
    Publication date: August 10, 2017
    Inventor: Nicholas B. Lydon
  • IMMUNOGLOBULINS AND VARIANTS DIRECTED AGAINST PATHOGENIC MICROBES
    Publication number: 20170166629
    Abstract: Anti-microbial monoclonal antibodies and variant antibodies having a heavy chain constant regions with at least one amino acid substitution are provided. Such antibodies may be used to prevent or treat microbial infections.
    Type: Application
    Filed: August 15, 2016
    Publication date: June 15, 2017
    Inventor: Nicholas B. LYDON
  • Immunoglobulins and variants directed against pathogenic microbes
    Patent number: 9416171
    Abstract: Anti-microbial monoclonal antibodies and variant antibodies having a heavy chain constant regions with at least one amino acid substitution are provided. Such antibodies may be used to prevent or treat microbial infections.
    Type: Grant
    Filed: June 23, 2014
    Date of Patent: August 16, 2016
    Inventor: Nicholas B. Lydon
  • IMMUNOGLOBULINS AND VARIANTS DIRECTED AGAINST PATHOGENIC MICROBES
    Publication number: 20160115222
    Abstract: Anti-SpA murine, chimeric and humanized monoclonal antibodies, and variant antibodies having a heavy chain with at least one amino acid substitution are provided. Such antibodies may be used to prevent or treat microbial infections.
    Type: Application
    Filed: October 26, 2015
    Publication date: April 28, 2016
    Inventor: Nicholas B. Lydon
  • IMMUNOGLOBULINS AND VARIANTS DIRECTED AGAINST PATHOGENIC MICROBES
    Publication number: 20160068589
    Abstract: Anti-SpA murine, chimeric and humanized monoclonal antibodies, and variant antibodies having a heavy chain with at least one amino acid substitution are provided. Such antibodies may be used to prevent or treat microbial infections.
    Type: Application
    Filed: June 27, 2014
    Publication date: March 10, 2016
    Inventor: Nicholas B. Lydon
  • IMMUNOGLOBULINS AND VARIANTS DIRECTED AGAINST PATHOGENIC MICROBES
    Publication number: 20150166640
    Abstract: Anti-microbial monoclonal antibodies and variant antibodies having a heavy chain constant regions with at least one amino acid substitution are provided. Such antibodies may be used to prevent or treat microbial infections.
    Type: Application
    Filed: June 23, 2014
    Publication date: June 18, 2015
    Inventor: Nicholas B. Lydon